What is the share price of Johnson Pharmacare Ltd (JOHNPHARMA) today?
The share price of JOHNPHARMA as on 20th May 2025 is ₹0.94. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Johnson Pharmacare Ltd (JOHNPHARMA) share?
The past returns of Johnson Pharmacare Ltd (JOHNPHARMA) share are- Past 1 week: 5.75%
- Past 1 month: -6.12%
- Past 3 months: -7.07%
- Past 6 months: -22.69%
- Past 1 year: -23.33%
- Past 3 years: -16.36%
- Past 5 years: 820%
What are the peers or stocks similar to Johnson Pharmacare Ltd (JOHNPHARMA)?
The peers or stocks similar to Johnson Pharmacare Ltd (JOHNPHARMA) include:What is the market cap of Johnson Pharmacare Ltd (JOHNPHARMA) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Johnson Pharmacare Ltd (JOHNPHARMA) is ₹50.60 Cr as of 20th May 2025.What is the 52 week high and low of Johnson Pharmacare Ltd (JOHNPHARMA) share?
The 52-week high of Johnson Pharmacare Ltd (JOHNPHARMA) is ₹1.44 and the 52-week low is ₹0.81.What is the PE and PB ratio of Johnson Pharmacare Ltd (JOHNPHARMA) stock?
The P/E (price-to-earnings) ratio of Johnson Pharmacare Ltd (JOHNPHARMA) is -253. The P/B (price-to-book) ratio is 0.89.Which sector does Johnson Pharmacare Ltd (JOHNPHARMA) belong to?
Johnson Pharmacare Ltd (JOHNPHARMA) belongs to the Health Care sector & Pharmaceuticals sub-sector.How to buy Johnson Pharmacare Ltd (JOHNPHARMA) shares?
You can directly buy Johnson Pharmacare Ltd (JOHNPHARMA) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Johnson Pharmacare Ltd
JOHNPHARMA Share Price
JOHNPHARMA Stock Scorecard
Performance
AvgPrice return has been average, nothing exciting
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
LowProfitability and efficiency haven't been upto the mark
Entry point
AvgThe stock is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
JOHNPHARMA Performance & Key Metrics
No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
---|---|---|
-722.86 | 0.89 | — |
Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
---|---|---|
44.82 | 6.38 | 0.56% |
JOHNPHARMA Analyst Ratings & Forecast
Price Upside
Earnings Growth
Rev. Growth
JOHNPHARMA Company Profile
Johnson Pharmacare Ltd is currently not engaged in any business activities and has not generated any revenues.
JOHNPHARMA Similar Stocks (Peers)
Compare with peersJOHNPHARMA Forecasts
JOHNPHARMA Forecast
JOHNPHARMA
Income
Balance Sheet
Cash Flow
JOHNPHARMA Income Statement
Financial Year | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | TTM | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total Revenue | 0.00 | 0.05 | 0.00 | 0.92 | 0.00 | 0.76 | 3.26 | 2.53 | 0.00 | — | ||||||||||
Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.65 | 2.69 | 2.02 | 0.00 | 0.07 | ||||||||||
Power & Fuel Cost | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||||||||
Employee Cost | 0.01 | 0.03 | 0.03 | 0.02 | 0.02 | 0.02 | 0.10 | 0.07 | 0.00 | |||||||||||
Selling & Administrative Expenses | 0.11 | 0.09 | 0.03 | 0.01 | 0.07 | 0.08 | 0.34 | 0.21 | 0.20 | |||||||||||
Operating & Other expenses | 0.01 | 0.00 | 0.00 | 0.90 | -0.00 | 0.01 | -0.00 | 1.55 | 0.00 | |||||||||||
EBITDA | -0.13 | -0.07 | -0.06 | -0.01 | -0.09 | 0.00 | 0.13 | -1.32 | -0.20 | -0.07 | ||||||||||
Depreciation/Amortization | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | ||||||||||
PBIT | -0.13 | -0.07 | -0.06 | -0.01 | -0.09 | 0.00 | 0.13 | -1.32 | -0.20 | -0.07 | ||||||||||
Interest & Other Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | ||||||||||
PBT | -0.13 | -0.07 | -0.06 | -0.01 | -0.09 | 0.00 | 0.13 | -1.32 | -0.20 | -0.07 | ||||||||||
Taxes & Other Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.04 | -0.04 | 0.00 | — | ||||||||||
Net Income | -0.13 | -0.07 | -0.06 | -0.01 | -0.09 | 0.00 | 0.09 | -1.28 | -0.20 | -0.07 | ||||||||||
EPS | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | 0.00 | 0.00 | -0.02 | -0.00 | -0.00 | ||||||||||
DPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||
Payout ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | 0.00 | 0.00 | 0.00 | 0.00 |
JOHNPHARMA Company Updates
Annual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFJOHNPHARMA Past Performance & Peer Comparison
Health CarePharmaceuticals
Valuation
Technical
Forecast
Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
---|---|---|---|
Johnson Pharmacare Ltd | -253.00 | 0.89 | — |
Sun Pharmaceutical Industries Ltd | 43.35 | 6.19 | 0.78% |
Cipla Ltd | 22.85 | 4.49 | 1.07% |
Torrent Pharmaceuticals Ltd | 67.49 | 16.30 | 0.85% |
JOHNPHARMA Stock Price Comparison
Compare JOHNPHARMA with any stock or ETFJOHNPHARMA Shareholdings
JOHNPHARMA Promoter Holdings Trend
JOHNPHARMA Institutional Holdings Trend
In last 3 months, retail holding in the company has almost stayed constant
In last 3 months, foreign institutional holding of the company has almost stayed constant
JOHNPHARMA Shareholding Pattern
JOHNPHARMA Shareholding History
smallcases containing JOHNPHARMA stock
Looks like this stock is not in any smallcase yet.
JOHNPHARMA Events
JOHNPHARMA Dividend Trend
JOHNPHARMA has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
JOHNPHARMA Dividends
JOHNPHARMA Stock News & Opinions
Johnson Pharmacare will hold a meeting of the Board of Directors of the Company on 23 May 2025.Powered by Capital Market - Live
Net loss of Johnson Pharmacare reported to Rs 0.03 crore in the quarter ended December 2024. There were no net profit/loss reported during the previous quarter ended December 2023. There were no Sales reported in the quarter ended December 2024 and during the previous quarter ended December 2023.Powered by Capital Market - Live
Johnson Pharmacare will hold a meeting of the Board of Directors of the Company on 31 January 2025.Powered by Capital Market - Live
Johnson Pharmacare reported no net profit/loss in the quarter ended September 2024 and during the previous quarter ended September 2023. There were no Sales reported in the quarter ended September 2024 and during the previous quarter ended September 2023.Powered by Capital Market - Live
Johnson Pharmacare will hold a meeting of the Board of Directors of the Company on 13 November 2024.Powered by Capital Market - Live
Johnson Pharmacare announced that the Annual General Meeting (AGM) of the company will be held on 28 September 2024.Powered by Capital Market - Live
Net Loss of Johnson Pharmacare reported to Rs 0.04 crore in the quarter ended June 2024 as against net loss of Rs 0.19 crore during the previous quarter ended June 2023. There were no Sales reported in the quarter ended June 2024 and during the previous quarter ended June 2023.Powered by Capital Market - Live
Johnson Pharmacare will hold a meeting of the Board of Directors of the Company on 1 August 2024.Powered by Capital Market - Live
Sun and Shine Worldwide renames as ‘Johnson Pharmacare’

Sun and Shine Worldwide to change its name as ‘Johnson Pharmacare’

In last 6 months, promoter holding in the company has almost stayed constant
Pledged promoter holdings is insignificant